The Story Behind the Cover Picture
Babylonian clay tablet of the liver
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:1-2
.
(28 February 2023)
Original Article
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:3-19
.
(28 February 2023)
Nonalcoholic steatohepatitis critically promotes the I/R-induced decreases of cardiolipins and increase of ceramides, which is linked to the exaggerated I/R injury in the mouse liver of nonalcoholic steatohepatitis.
Validation of the Enhanced Recovery after Surgery (ERAS) society recommendations for liver surgery: a prospective, observational study
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:20-36
.
(28 February 2023)
Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:37-44
.
(28 February 2023)
The novel combination of nab-paclitaxel plus S-1 as first-line treatment for advanced biliary tract adenocarcinoma yieled comparable efficacy to the standard regimens in terms of ORR, PFS and OS. The favorable tolerability makes it a potential selection of non-platinum and -gemcitabine-based regimen.
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:45-55
.
(28 February 2023)
Review Article
A narrative review of the current and future role of robotic surgery in liver surgery and transplantation
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:56-68
.
(28 February 2023)
The article reviewed the role of minimally invasive surgery in the field of liver surgery and transplantation, with a particular focus on the robotic approach. Robotic surgery, especially in living donation, can be performed safely in properly selected patients by teams with high expertise.
Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:69-83
.
(28 February 2023)
Surgery remains the best treatment for localized PanNETs, but it also has an important role in metastatic disease. Surgical debulking of liver metastasis in selected patients with metastatic PanNETs may confer a survival benefit, improve symptoms, and allow systemic therapies to be more efficacious.
Editorial
Is HPB robotic-assisted surgery an evolution or a revolution in laparoscopy?
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:84-87
.
(28 February 2023)
Liver metastasis of pancreatic cancer: the new choice at the crossroads
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:88-91
.
(28 February 2023)
Is there a survival benefit of a robotic approach to pancreatoduodenectomy for pancreatic cancer?
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:92-94
.
(28 February 2023)
Management of decompensated liver cirrhosis in the surgical intensive care unit
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:95-98
.
(28 February 2023)
Pushing the limits for the surgical treatment of intrahepatic cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:99-104
.
(28 February 2023)
Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:105-109
.
(28 February 2023)
The French guidelines for alcohol-related liver disease—what’s new, what’s not and what’s still needed
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:110-115
.
(28 February 2023)
Liver transplantation for unresectable colorectal liver metastases (CRLM) using extended criteria donor (ECD) grafts: proceed with caution
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:116-117
.
(28 February 2023)
Tailoring stepwise treatment for Budd-Chiari syndrome: insights from the Asian Pacific Association for the Study of the Liver (APASL) consensus guidance
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:118-120
.
(28 February 2023)
East meets West: what opportunities arise in comparing international guidelines for management of cirrhosis?
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:121-123
.
(28 February 2023)
Editorial Commentary
Ascites and complications: getting to the root of the trouble
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:124-127
.
(28 February 2023)
Optimizing management of patients with pancreatic exocrine insufficiency
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:128-130
.
(28 February 2023)
Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:131-134
.
(28 February 2023)
A new era for hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:135-136
.
(28 February 2023)
Viewpoint
Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:137-139
.
(28 February 2023)
Letter to the Editor
Novel preoperative strategies to improve hepatocellular carcinoma resectability
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:140-141
.
(28 February 2023)
The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:142-143
.
(28 February 2023)
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular carcinoma”
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:144-147
.
(28 February 2023)
The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumab
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:148-150
.
(28 February 2023)
Can a laparoscopic surgery be an alternative to transjugular intrahepatic portosystemic shunts (TIPS) for the treatment of portal hypertensive bleeding?
HepatoBiliary Surgery and Nutrition
2023;
12
(1)
:151-154
.
(28 February 2023)
